Combined Synopsis/Solicitation to provide quality control (QC) products for testing Clinical Chemistry, and Immunochemistry Testing for the Brooke Army Medical Center (BAMC), JBSA, Fort Sam Houston, TX.

The Government’s requirement is to obtain quality control reagents and related consumables for an expert quality control program for Department of Pathology and Laboratory Services at Brooke Army Medical Center Core Laboratory in Fort Sam Houston, Texas 78234. Please complete the SF 1449: Blocks 12, 17 (to include CAGE code and the Unique Entity ID Number) and 30A – C. For all amendments issued, if any please complete the SF 30: Blocks 8, 15A – C, Point of Contact Information (Name, Telephone Number, Fax Number, and Email) and a statement that the offeror will hold its quote firm for at least 90 days from the due date for receipt of quotes, subject to any changes that may occur as a result of discussions (if applicable).

Please complete provisions, as listed in the solicitation. Alternately, complete all provisions in SAM and provide confirmation of completion and accuracy with offer. Potential contractors must be registered in the System for Award Management (SAM) to be eligible for award. The SAM website is http://www.sam.gov. Offers are due by 9 September 2024, 1:00 PM, Central Standard Time (unless extended via amendment).

Offers shall be submitted via e-mail to medina.l.woodson.civ@health.mil and salameya.paulouskaya2.civ@health.mil. Quotes received after the deadline will be considered untimely and will not be eligible for award. The deadline for questions is 30 August 2024, 4:00 PM, Central Standard Time. All questions must be submitted in writing to medina.l.woodson.civ@health.mil and salameya.paulouskaya2.civ@health.mil. Electronic submissions with files larger than 20MB will need to be submitted in separate emails.

All emails, regardless of the size, need to be received by the Government server, by the stated date and time. It is the offeror's responsibility to ensure the Government receives the entire quote.